UB collaborative study published in Scientific Reports

Scientific Reports.

By Kara Sweet

Published June 24, 2019 This content is archived.

A study led by Professor Javier Blanco, Clin. Biochem., PhD, was recently published in Scientific Reports.

Print

Related Links

The article, titled "Contribution of DNA methylation to the expression of FCGRT in human liver and myocardium," shows that DNA methylation, an important epigenetic determinant of gene expression, impacts the expression of FcRn in human liver and myocardium (heart). This study provides a foundation to further define the contribution of epigenetic factors during the control of FcRn expression and the traffic of IgG & therapeutic mAbs in humans. The receptor FcRn mediates the cellular traffic of immunoglobulin G (IgG), albumin, and a variety of clinically relevant monoclonal antibody drugs (mAbs).

The publication was authored by postdoctoral associate Romina B. Cejas, PhD candidate Daniel F. Ferguson, former postdoctoral associate Adolfo Quiñones-Lombraña, and Javier Blanco from the UB School of Pharmacy and Pharmaceutical Sciences, and by senior bioinformatics analyst Jonathan Bard, New York Center of Excellence in Bioinformatics and Life Sciences.

Scientific Reports is an online, open access journal from the publishers of Nature that publishes scientifically valid primary research from all areas of the natural and clinical sciences. 

For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and ranked as one of the top 25 schools of pharmacy and pharmaceutical sciences in the United States.